Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5G
- Development stage
- Unknown
- Lead developer
- Neurogenics Therapeutics
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
5G is an oral dietary supplement developed by Neurogenics Therapeutics, specifically formulated to support nerve health and address symptoms associated with peripheral neuropathy. The name 5G is derived from its five key active ingredients: methylcobalamin (Vitamin B12), benfotiamine (Vitamin B1), pyridoxal-5-phosphate (Vitamin B6), alpha-lipoic acid, and riboflavin (Vitamin B2). These components work synergistically to promote nerve regeneration, enhance myelin sheath integrity, and reduce oxidative stress. Methylcobalamin and benfotiamine provide highly bioavailable forms of essential vitamins that support nerve cell metabolism and structure, while alpha-lipoic acid acts as a potent antioxidant to mitigate nerve damage caused by free radicals. The product is marketed as a commercial solution for individuals seeking to manage neuropathic discomfort and maintain healthy neurological function.
- Brand names
- 5G5G Nerve Support
- Other names
- Neurogenics 5GNeurogenics5GNeurogenics-5G5G Nerve Support Formula
02
Targets
DDC (Aromatic L-amino acid decarboxylase)GSR (Glutathione reductase)MTR (Methionine synthase)TKT (Transketolase)
Beyond the preview
Go deeper on 5G.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5G.